Zusammenfassung
Delirium ist in der Palliativmedizin ein weit verbreitetes und stark belastendes Symptom, dessen Ursachen und Entstehung sind multifaktoriell sind. Studien belegen, dass ein Zusammenspielen bestimmter Auslöser die Entstehung eines Deliriums begünstigen kann. Manche dieser Auslöser sind reversibel. Dieser Fallbericht präsentiert ein reversibles Delirium bei einer Patientin mit fortgeschrittener Krebserkrankung. Des Weiteren findet sich eine Liste möglicher, reversibler medikamentöser Ursachen für ein Delirium, welche vor allem bei älteren Patienten hilfreich sein kann.
Summary
Delirium is still one of the most common and distressing symptoms in palliative care patients. Causes and pathophysiology of this neuropsychiatric dysfunction are multifactorial. Recent studies indicate that the interaction of special triggers facilitates development of delirium. Some of them are reversible. This case report presents a reversible delirium in an advanced cancer patient and offers a list of possible delirogen medications. This list might be useful to prevent delirium, particularly in older people.
This is a preview of subscription content, log in via an institution to check access.
References
http://symptomresearch.nih.gov/chapter_5/sec2/cebs2pg1.htm Manual of Psychiatric Disorders 4th edition (DSM-IV) (American Psychiatric Association (APA), 1994). accessed 6.3.2011
Centeno C, Sanz A, Bruera E. Delirium in advanced cancer patients. Palliat Med, 18: 184–194, 2004. Review
Liptzin B, Levkoff SE. An empirical study of delirium subtypes. Br J Psychiatry, 161: 843–845, 1992
Bush SH, Bruera E. The assessment and management of delirium in cancer patients. Oncologist 14: 1039–1049, 2009. Review
Lawlor PG, Gagnon B, Mancini IL, et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med, 160: 786–794, 2000
Breitbart W, Strout D. Delirium in the terminally ill. Clin Geriatr Med, 16: 357–372, 2000. Review
Ljubisavljevic V, Kelly B. Risk factors for development of delirium among oncology patients. Gen Hosp Psychiatry, 25: 345–352, 2003
Gaudreau JD, Gagnon P, Harel F, et al. Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol, 23(27): 6712–6718, 2005
Kruszewski SP, Paczynski RP, Kahn DA. Gabapentin-induced delirium and dependence. J Psychiatr Pract, 15(4): 314–319, 2009
Campbell N, Boustani MA, Ayub A, et al.Pharmacological management of delirium in hospitalized adults – a systematic evidence review. J Gen Intern Med, 24: 848–853, 2009. Review
Tabet N, Howard R. Pharmacological treatment for the prevention of delirium: review of current evidence. Int J Geriatr Psychiatry, 24: 1037–1044, 2009. Review
Khurana V, Gambhir IS, Kishore D. Evaluation of delirium in elderly: a hospital-based study. Geriatr Gerontol Int, 2011. DOI:10.1111/j.1447-0594.2011.00710.x. Epub 2011 May 18
Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int, 107: 543–551, 2010
Caraceni A, Nanni O, Maltoni M, et al. Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care. Cancer, 89: 1145–1149, 2000
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kierner, K., Jagsch, C. & Watzke, H. Reversible delirium in an advanced cancer patient. Wien Med Wochenschr 162, 8–10 (2012). https://doi.org/10.1007/s10354-011-0048-x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10354-011-0048-x